The effect of RG-II on mice carrying lymphoma C57BL6 was further verified, and the results showed that the activity of CD8+T cells was significantly enhanced after the administration of RG-II and that the tumor growth and metastasis of mice were effectively alleviated [9]. The gene discussed is CD8A; the disease is neoplasm.